The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-3-(4-(8-isopropyl-5-oxo-4-propyl-4,5,7,8-tetrahydro-1H-imidazo[1,2-g]purin-2-yl)bicyclo[2.2.2]octan-1-yl)propanoic acid ID: ALA216200
PubChem CID: 135428653
Max Phase: Preclinical
Molecular Formula: C24H35N5O3
Molecular Weight: 441.58
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCN1C(=O)N2C[C@@H](C(C)C)N=C2c2[nH]c(C34CCC(CCC(=O)O)(CC3)CC4)nc21
Standard InChI: InChI=1S/C24H35N5O3/c1-4-13-28-20-18(19-25-16(15(2)3)14-29(19)22(28)32)26-21(27-20)24-10-7-23(8-11-24,9-12-24)6-5-17(30)31/h15-16H,4-14H2,1-3H3,(H,26,27)(H,30,31)/t16-,23?,24?/m0/s1
Standard InChI Key: SYGGDNIWKSBCDC-JEACLXLTSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
-1.6125 -1.8776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.8555 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6627 -0.5522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1205 -0.2651 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2973 1.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9498 1.8334 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8223 -3.1099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1482 -4.4509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8066 -5.4541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6120 1.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4602 0.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9082 1.0973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3211 2.5517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2810 3.6234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8329 3.2581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4966 2.8614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2244 1.5566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2125 -2.9168 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7628 2.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7814 1.7701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2455 2.1003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6018 3.2462 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0600 1.2190 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3414 -0.5743 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5683 0.7068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5402 1.8334 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9539 1.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8214 -0.2430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2446 1.9975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2894 1.4073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2338 3.1975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 4 1 0
3 4 2 0
4 5 1 0
5 6 2 0
3 7 1 0
6 7 1 0
2 8 1 0
8 9 1 0
9 10 1 0
6 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
11 16 1 0
15 16 1 0
11 17 1 0
14 18 1 0
17 18 1 0
1 19 2 0
14 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
22 24 2 0
1 25 1 0
3 26 1 0
25 26 1 0
26 27 2 0
27 28 1 0
25 29 1 0
28 29 1 0
28 30 1 1
30 31 1 0
30 32 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 441.58Molecular Weight (Monoisotopic): 441.2740AlogP: 4.30#Rotatable Bonds: 7Polar Surface Area: 101.89Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.87CX Basic pKa: 5.09CX LogP: 2.64CX LogD: 0.81Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.66Np Likeness Score: 0.09
References 1. Vu CB, Kiesman WF, Conlon PR, Lin KC, Tam M, Petter RC, Smits G, Lutterodt F, Jin X, Chen L, Zhang J.. (2006) Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists., 49 (24): [PMID:17125265 ] [10.1021/jm060539t ]